| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,091 | 0,102 | 08.06. | |
| 0,091 | 0,102 | 08.06. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 0,700 | 1.000 | |||
| 0,102 | 1.600 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/psh0.htm [/URL] | ||||
| 1.600 | 0,091 | |||
| 4.729 | 0,090 | |||
| 5.000 | 0,086 | |||
| 12.676 | 0,071 | |||
| 1.078 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 25.083 | 0,104 | 2.600 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:47 | 0,090 | 78 |
| 12:39:14 | 0,091 | 3.000 |
| 10:01:33 | 0,091 | 122 |
| 09:38:29 | 0,091 | 2.146 |
| 09:17:17 | 0,091 | 3.315 |
| 09:04:34 | 0,106 | 820 |
| Tagesumsatz Xetra | 0,000 -0,22 % | 9.642 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.04. | Sernova Biotherapeutics Inc: Sernova closes financings, issues units for debts | 66 | Stockwatch | ||
| SERNOVA BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 23.04. | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | 830 | Newsfile | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| 10.04. | Sernova Biotherapeutics Inc: Sernova shareholders re-elect six directors at AGM | 73 | Stockwatch | ||
| 09.04. | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders | 534 | Newsfile | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherapeutics Inc. (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative... ► Artikel lesen | |
| 24.03. | Sernova Biotherapeutics Inc: Sernova closes $2.1-million private placement | 57 | Stockwatch |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mo | Aclarion, Inc.: Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal | GlobeNewswire (Europe) | BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers... ► Artikel lesen | |
| Mo | Smith & Nephew Plc: Smith+Nephew announces first clinical cases with the next generation CORI?XT Handheld Robotics Platform across knee and shoulder arthroplasty | GlobeNewswire (Europe) | Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next-generation CORI? XT Handheld Robotics Platform... ► Artikel lesen | |
| Mo | Medical Care Technologies Inc.: MDCE's Infinite Auctions Introduces New Auction Platform Combining Straight Bidding with Real-Time Buy It Now Functionality | ACCESS Newswire | Company unveils a modern auction experience that eliminates proxy bidding while introducing live Buy It Now functionality during premium sports memorabilia auctions. MESA, AZ / ACCESS Newswire / June... ► Artikel lesen | |
| Mo | Medtronic Receives FDA Clearance for Nellcor Pulse Oximetry System With Nell-EQ Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse Patients and Conditions | ACCESS Newswire | This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.... ► Artikel lesen | |
| Mo | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Group (DE) | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |